Search by Drug Name or NDC
NDC 70839-0150-30 Tekturna 150 mg/1 Details
Tekturna 150 mg/1
Tekturna is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by LXO US Inc.. The primary component is ALISKIREN HEMIFUMARATE.
MedlinePlus Drug Summary
Aliskiren is used alone or in combination with some medications to treat high blood pressure. Aliskiren is in a class of medications called direct renin inhibitors. It works by decreasing certain natural chemicals that tighten the blood vessels, so blood vessels relax and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 70839-0150-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Aliskiren
Product Information
| NDC | 70839-0150 |
|---|---|
| Product ID | 70839-150_03ab8798-2a41-13ea-e063-6294a90a90b7 |
| Associated GPIs | 36170010100320 |
| GCN Sequence Number | 062289 |
| GCN Sequence Number Description | aliskiren hemifumarate TABLET 150 MG ORAL |
| HIC3 | A4T |
| HIC3 Description | RENIN INHIBITOR, DIRECT |
| GCN | 98077 |
| HICL Sequence Number | 034493 |
| HICL Sequence Number Description | ALISKIREN HEMIFUMARATE |
| Brand/Generic | Brand |
| Proprietary Name | Tekturna |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | aliskiren hemifumarate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | ALISKIREN HEMIFUMARATE |
| Labeler Name | LXO US Inc. |
| Pharmaceutical Class | Renin Inhibitor [EPC], Renin Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021985 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70839-0150-30 (70839015030)
| NDC Package Code | 70839-150-30 |
|---|---|
| Billing NDC | 70839015030 |
| Package | 30 TABLET, FILM COATED in 1 BOTTLE (70839-150-30) |
| Marketing Start Date | 2017-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 10.1636 |
| Pricing Unit | EA |
| Effective Date | 2024-01-15 |
| NDC Description | TEKTURNA 150 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |